Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
Su‐Hyun Kim(National Cancer Center), Ho Jin Kim(National Cancer Center), Ha Young Shin(Yonsei University), Tai‐Seung Nam(Chonnam National University Hospital), Seol‐Hee Baek(Korea University Medical Center), Woojun Kim(National Cancer Center), Jong Seok Bae(Hallym University), Tae-Kyeong Lee(Gachon University Gil Medical Center), So‐Young Huh(Kosin University Gospel Hospital), In Soo Joo(Ajou University), Woo Kyung Kim(Inje University), Kee Hong Park(Hallym University), Seong‐il Oh(Kyung Hee University), Yoon‐Ho Hong(Seoul Metropolitan Government), Jeeyoung Oh(Université Paris-Sud), Eunbin Cho(Jeonju University), Young Nam Kwon(Yonsei University), Soonwook Kwon(Inha University Hospital), Eun‐Jae Lee(Ulsan College), Hung Youl Seok(Keimyung University), Sun‐Young Kim(Hanyang Cyber University), Sung‐Min Kim(Seoul National University Hospital), Nam‐Hee Kim(Korea National Institute of Health), Jin-Hong Shin(Chosun University Hospital), Jiwon Yang(Ulsan College), Sun‐Young Oh(Inje University Busan Paik Hospital), Min Su Park(Yeungnam University College), Ju‐Hong Min(Samsung Medical Center), Jun Soon Kim(Konkuk University Medical Center), Hyung-Soo Lee(Seoul Medical Center), Hyun-June Shin(Yonsei University), Jeong Bin Bong(Chosun University Hospital)
Cited by 6
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
|The Lancet|2019|722
Neuromyelitis optica
|Nature Reviews Disease Primers|2020|464
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284